Legend has it that its flowers are the most expressive on the market.

Swiss Medical Cannabis introduces you to the White Widow CBD flower, an original flower produced by the brand GreenGold ! Its added value? An inimitable scent. Surely the most astonishing of our creations. We don't expect you to believe us - just try it! Now available from SMC Laboratories®.

Our CBD-rich White Widow CBD flower genetics are a Greenhouse grown under the best conditions to guarantee you a quality organic product free of pesticides, heavy metals and GMOs.

Once finished, we guarantee a curing of 3 to 8 weeks so that the terpenes take all their rise and that the organoleptic qualities reach their apogee allowing thesmell of the flower to transcend all your senses.

Agricultural hemp*(100%)
Cannabidiol (CBD) less than 10% THC
THC less than 0.3%

*Derived from organic farming and the Common Catalogue of Varieties of European Agricultural Species.
CBD Flower Guaranteed free of pesticides, fungicides, chemical fertilizers, heavy metals, additives and allergens.

For private use only.
Do not smoke.

White Widow CBD flower should be stored in a dry place.
Use by date indicated on packaging.

Fleurs Européennes :
Chaque batch de Fleurs de chanvre expédié en Europe fait ainsi l’objet d’une analyse par un laboratoire indépendant en Suisse, puis d’une contre-analyse par un acteur indépendant en Europe.
Ces deux contrôles de sécurité assurent que nos fleurs mise sur le marché respectent scrupuleusement la réglementation Européenne en matière de Taux de THC (<0,3%).
Nous nous assurons également que les fleurs de chanvre proviennent du catalogue Européen Des variétés agricoles autorisées.

CBD flowers sold in Switzerland:
As required by our country's regulations, we assure our Swiss customers that the flowers sold by our company have a THC content of less than 1%.

All this data is the property of SWISS MEDICAL CANNABIS SA. under the terms of Directives 91/250/EEC and 96/9/EC, which grant copyright protection to computer programs and databases respectively. SWISS MEDICAL CANNABIS SA. reserves the right to take legal action against any copying or reproduction of our information.

We also reserve the right to file a claim for damages, in accordance with article L. 331-1-3 of the CPI, which states that "in order to determine the damages, the court shall take into consideration the negative economic consequences, including loss of earnings, suffered by the injured party, the profits made by the infringer and the moral prejudice caused to the owner of these rights as a result of the infringement.